Danaher: Aktie für die Ewigkeit überzeugt erneut

Beim US-Mischkonzern Danaher – specialized in the field of Life Science, Medizintechnik and Umwelt – laufen de Geschäfte weiterhin gut. If you leave the service, you can find more information here.

Then your company’s service may have influenced the market’s costs. The net profit of US$818 million was a profit for Action (EPS) of US$1.12 revenue. Basic earnings per share were US$1.71, German would be US$1.57. The value of 3.1 percent at US$5.8 billion is a matter of time in the life sciences and diagnostics segments, while the biotechnology segment ushers in a light war.

Ausblick

During the fourth quarter of 2024, Danaher was a lighter background of the developments in the intelligent Prozentbereich, which offered a broader mirror of the history of the world. Long-term business continuity is likely to be supported by your large portfolio and such excellent prospects, especially by strategic acquisitions and innovations. Analysts have rated Danaher positively and seeing how the numbers have been examined in the year 2025, a study in biotechnology is a fact. The action is carried out more as “Kauf” and continues in the United States and that is what matters.

Bewertung

The promotion became a Kurs-Gewinn-Verhältnis (KGV) of beef 48 and is really worthy of sport. It can take a year for the old stone to nach and the longer than 40 percent will take. Then it will last more than 25 years of dividends, while the last few years have been continuously increasing. After you perform the action, new settings may be activated and displayed on the pages.